| |
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2.
Connor RI, Sakharkar M, Rappazzo CG, Kaku CI, Curtis NC, Shin S, Wieland-Alter WF, Wentworth J, Mielcarz DW, Weiner JA, Ackerman ME, Walker LM, Lee J, Wright PF
Pathog Immun. 2024;9(2):1-24. doi: 10.20411/pai.v9i2.679. Epub 2024 Jun 18.
PMID: 38933606 Nasal and pharyngeal mucosal immunity to poliovirus in children following routine immunization with inactivated polio vaccine (IPV) in the United States of America.
Godin A, Connor RI, Degefu HN, Rosato PC, Wieland-Alter WF, Axelrod KS, Kovacikova G, Weiner JA, Ackerman ME, Chen EY, Arita M, Bandyopadhyay AS, Raja AI, Modlin JF, Brickley EB, Wright PF
J Infect Dis. 2024 May 29; pii: jiae264. doi: 10.1093/infdis/jiae264. Epub 2024 May 29.
PMID: 38809190 Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages.
Chernyshev M, Sakharkar M, Connor RI, Dugan HL, Sheward DJ, Rappazzo CG, Stalmarck A, Forsell MNE, Wright PF, Corcoran M, Murrell B, Walker LM, Karlsson Hedestam GB
Nat Commun. 2023 Apr 19;14(1):2249. doi: 10.1038/s41467-023-37972-1. Epub 2023 Apr 19.
PMID: 37076511 Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike.
Crowley AR, Natarajan H, Hederman AP, Bobak CA, Weiner JA, Wieland-Alter W, Lee J, Bloch EM, Tobian AAR, Redd AD, Blankson JN, Wolf D, Goetghebuer T, Marchant A, Connor RI, Wright PF, Ackerman ME
Elife. 2022 Mar 15;11 doi: 10.7554/eLife.75228. Epub 2022 Mar 15.
PMID: 35289271 Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection.
Wright PF, Prevost-Reilly AC, Natarajan H, Brickley EB, Connor RI, Wieland-Alter WF, Miele AS, Weiner JA, Nerenz RD, Ackerman ME
J Infect Dis. 2022 Sep 28;226(7):1204-1214. doi: 10.1093/infdis/jiac065.
PMID: 35188974 Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2.
Natarajan H, Xu S, Crowley AR, Butler SE, Weiner JA, Bloch EM, Littlefield K, Benner SE, Shrestha R, Ajayi O, Wieland-Alter W, Sullivan D, Shoham S, Quinn TC, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Connor RI, Wright PF, Ackerman ME
BMC Immunol. 2022 Feb 16;23(1):7. doi: 10.1186/s12865-022-00480-w. Epub 2022 Feb 16.
PMID: 35172720 Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike.
Crowley AR, Natarajan H, Hederman AP, Bobak CA, Weiner JA, Wieland-Alter W, Lee J, Bloch EM, Tobian AAR, Redd AD, Blankson JN, Wolf D, Goetghebuer T, Marchant A, Connor RI, Wright PF, Ackerman ME
medRxiv. 2021 Oct 28; pii: 2021.10.27.21265574. doi: 10.1101/2021.10.27.21265574. Epub 2021 Oct 28.
PMID: 34729565 Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2.
Natarajan H, Xu S, Crowley AR, Butler SE, Weiner JA, Bloch EM, Littlefield K, Benner SE, Shrestha R, Ajayi O, Wieland-Alter W, Sullivan D, Shoham S, Quinn TC, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Connor RI, Wright PF, Ackerman ME
medRxiv. 2021 Aug 8; pii: 2021.08.06.21261710. doi: 10.1101/2021.08.06.21261710. Epub 2021 Aug 8.
PMID: 34401890 Mucosal immunity to poliovirus.
Connor RI, Brickley EB, Wieland-Alter WF, Ackerman ME, Weiner JA, Modlin JF, Bandyopadhyay AS, Wright PF
Mucosal Immunol. 2022 Jan;15(1):1-9. doi: 10.1038/s41385-021-00428-0. Epub 2021 Jul 8.
PMID: 34239028 Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.
Natarajan H, Crowley AR, Butler SE, Xu S, Weiner JA, Bloch EM, Littlefield K, Wieland-Alter W, Connor RI, Wright PF, Benner SE, Bonny TS, Laeyendecker O, Sullivan D, Shoham S, Quinn TC, Larman HB, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Ackerman ME
mBio. 2021 Apr 20;12(2) doi: 10.1128/mBio.00765-21. Epub 2021 Apr 20.
PMID: 33879585 View more publications on PubMed |